About GSK 219685
This app has been created exclusively for participants in the medical study for GSK 219685. It contains Televisit functionality and allows participants to complete questionnaires.
A seamless Phase 1/2, observer-blind, randomized, placebo-controlled, multicenter study to assess the safety, clinical efficacy and immunogenicity of the UTI vaccine when administered to adults 18 through 64 years of age.
Similar Apps
Medable
Medable is on a mission to enable effective therapies to people faster....
J1I-MC-GZQD
This app has been exclusively created for participants in the medical study...
Avanti
For invited Avanti study participants. You will use this app to consent...
GSK 219855 France
You are invited to participate in the GSK BLISSc-ILD OLE study. This...
GSK 221458
This app is specifically intended for participants in the GSK 221458 study...
J3M-MC-JZQH
This app has been exclusively created for participants with Resected or Unresectable...
